A detailed history of Steel Peak Wealth Management LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Steel Peak Wealth Management LLC holds 101,998 shares of VRCA stock, worth $810,884. This represents 0.04% of its overall portfolio holdings.

Number of Shares
101,998
Previous 122,836 16.96%
Holding current value
$810,884
Previous $895,000 9.5%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$7.95 - $7.95 $165,662 - $165,662
-20,838 Reduced 16.96%
101,998 $810,000
Q2 2024

Jul 16, 2024

SELL
$5.89 - $9.56 $88,939 - $144,356
-15,100 Reduced 10.95%
122,836 $895,000
Q1 2024

Apr 17, 2024

BUY
$4.74 - $6.81 $2,844 - $4,085
600 Added 0.44%
137,936 $816,000
Q4 2023

Jan 23, 2024

BUY
$2.93 - $7.32 $1,025 - $2,562
350 Added 0.26%
137,336 $1.01 Million
Q3 2023

Nov 02, 2023

BUY
$3.75 - $7.46 $6,093 - $12,122
1,625 Added 1.2%
136,986 $531,000
Q1 2023

May 05, 2023

SELL
$2.88 - $8.51 $2,880 - $8,510
-1,000 Reduced 0.73%
135,361 $879,000
Q4 2022

Jan 25, 2023

BUY
$2.09 - $3.39 $3,552 - $5,763
1,700 Added 1.26%
136,361 $0
Q2 2022

Aug 02, 2022

BUY
$1.81 - $8.93 $2,262 - $11,162
1,250 Added 0.94%
134,661 $259,000
Q1 2022

May 10, 2022

BUY
$7.59 - $9.49 $1,518 - $1,898
200 Added 0.15%
133,411 $1.08 Million
Q4 2021

Jan 31, 2022

BUY
$9.1 - $13.36 $455 - $668
50 Added 0.04%
133,211 $1.22 Million
Q3 2021

Nov 15, 2021

BUY
$9.55 - $13.96 $1,910 - $2,792
200 Added 0.15%
133,161 $1.67 Million
Q3 2020

Oct 26, 2020

BUY
$6.16 - $10.3 $3,696 - $6,180
600 Added 0.45%
132,961 $1.03 Million
Q4 2019

Feb 06, 2020

BUY
$13.08 - $17.43 $1.73 Million - $2.31 Million
132,361 New
132,361 $2.1 Million

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Steel Peak Wealth Management LLC Portfolio

Follow Steel Peak Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steel Peak Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steel Peak Wealth Management LLC with notifications on news.